|
|
|
|
|
|
|
Cancer risks detailed for arthritis drugs
May 16 2006 7:18PM (CT)
CHICAGO (AP) - Rheumatoid arthritis patients taking Humira or Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a study led by the Mayo Clinic found.
|
|
|
Sugar cane cholesterol treatment faulted
May 16 2006 7:17PM (CT)
CHICAGO (AP) - German research casts doubt on the effectiveness of a sugar cane-based ingredient sold as a cholesterol treatment in One-A-Day vitamins and other products marketed in dozens of countries.
|
|
|
Conventional cancer beliefs may be wrong
May 16 2006 7:17PM (CT)
WASHINGTON (AP) - Lung cancer isn't common in people who never smoked. But when they do get it, doctors have long thought women were more likely to die than men. New research suggests the opposite.
|
|
|
Merck awaits FDA approval for Gardasil
May 16 2006 7:16PM (CT)
TRENTON, N.J. (AP) - Merck & Co., looking for a boost to fight off its Vioxx-related losses, could get it from the first big advance against cervical cancer in a half-century.
|
|
|
Groups want nanotech sunscreens pulled
May 16 2006 7:16PM (CT)
WASHINGTON (AP) - Sunscreens made with submicroscopic particles pose a health hazard and should be recalled, environmental groups said Tuesday in asking the government to increase regulation of growing uses of the science of nanotechnology.
|
|
|
FDA: Bausch & Lomb didn't disclose cases
May 16 2006 6:08PM (CT)
ROCHESTER, N.Y. (AP) - Bausch & Lomb Inc. failed to promptly notify federal regulators about 35 cases of a potentially blinding fungal infection among contact lens wearers in Singapore who reported using its newest contact lens cleaner, the Food and Drug Administration said Tuesday.
|
|
|
Officials to mull advice for mumps shots
May 16 2006 5:54PM (CT)
ATLANTA (AP) - Concerned by the recent mumps outbreak in the Midwest, federal health officials plan to review their advice for mumps shots.
|
|
|
Synthetic marijuana returning to market
May 16 2006 1:52PM (CT)
WASHINGTON (AP) - Seventeen years after it was withdrawn from U.S. markets, a synthetic version of the active ingredient in marijuana is going back on sale as a prescription treatment for the vomiting and nausea that often accompanies chemotherapy, its manufacturer said Tuesday.
|
|
|
Vote set on drug for Parkinson's dementia
May 16 2006 10:59AM (CT)
WASHINGTON (AP) - A drug that treats mild to moderate dementia in Alzheimer's disease patients appears to be effective in helping Parkinson's patients with dementia as well, though researchers are not sure the two conditions are distinct, according to Food and Drug Administration documents released Tuesday.
|
|
|
FDA delays approval of new sleeping pill
May 16 2006 9:48AM (CT)
WASHINGTON (AP) - Federal health officials held off Tuesday approving a new sleeping pill, telling Neurocrine Biosciences Inc. they need more time to review its application, the San Diego company said.
|
|
|
|
|
|